It also describes the symptoms of undifferentiated schizophrenia as well as the causes, diagnosis, and treatment of schizophrenia in the current context. Schizophrenia is a mental health condition ...

Once all of the test results are reviewed and alternative causes are ruled out, a definitive diagnosis of schizophrenia can be made. The first line of treatment for schizophrenia is psychotropic ...

A drug that has recently been approved for the treatment of schizophrenia could one day be prescribed to Alzheimer’s patients. Researchers are trialing Cobenfy to see if it effectively treats ...

Cobenfy’s approval marks a critical shift in schizophrenia treatment. (Image Credits: Pixabay) The FDA has recently approved Karuna/Bristol Myers Squibb’s KarXT (Cobenfy), an oral medication ...

What Happens in the Brain When a Person With Schizophrenia 'Hears Voices'? Oct. 3, 2024 — Auditory hallucinations are likely the result of abnormalities in two brain processes: a 'broken ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and EA Pharma (a subsidiary of Eisai Co., Ltd.) announce license agreement for evenamide in Japan and other Asian ...

Here’s what to know about the symptoms of psychosis versus schizophrenia, the differences between the two, and treatment options for each. Psychosis and schizophrenia have several things in common.

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.

If you or a loved one has schizophrenia, you may wonder how the condition will impact you as you age. Even with treatment, schizophrenia can affect your brain and body in different ways as you get ...